ANTICOV Trial
The Regulatory Sciences Senior Manager will provide strategic regulatory leadership across the joint DNDi–MMV platform, overseeing global regulatory strategies, interactions with authorities, and capacity strengthening for neglected disease product pipelines. Reporting to the Director of Regulatory Sciences, the role combines senior management, technical expertise, and advocacy to ensure efficient development, approval, and access to lifesaving medicines.
The ANTICOV clinical trial aimed to identify treatments to treat mild and moderate cases of COVID-19 early and prevent hospitalizations in low-resource settings across Africa, Asia, and Latin America. Launched in September 2020 by a 27-organization consortium coordinated by the Drugs for Neglected Diseases initiative (DNDi), it was one of the largest multi-country trials focusing exclusively on mild and moderate COVID-19 cases. The study was completed in December 2022, and its collaborative momentum led to the creation of the PANTHER platform to strengthen pandemic preparedness in Africa.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ANTICOV Trial.
ANTICOV Trial didn’t post a salary, so this is our estimate from similar listings.
15% above the average for this role
Regulatory Sciences Lead for DNDi–MMV Joint Regulatory Platform
Drugs for Neglected Diseases initiative
Executive Director, Regulatory Affairs
Beeline Medicines
Senior Manager, Global Regulatory Sciences EU & International
Bristol Myers Squibb
Senior Director, Global Regulatory Affairs
Jobgether
Senior Manager, Regulatory Affairs
Revolution Medicines
Director, Global CMC Regulatory
Revolution Medicines